CSIMarket
 
Icu Medical Inc  (NASDAQ: ICUI)
 
Price: $166.2900 $-3.56 -2.096%
Day's High: $171.69000244140625 Week Perf: -5.03 %
Day's Low: $ 165.58 30 Day Perf: -0.07 %
Volume (M): 241,539 52 Wk High: $ 192.85
Volume (M$): $ 0 52 Wk Avg: $141.38
Open: $171.69 52 Wk Low: $112.50



 Market Capitalization (Millions $) 4,188
 Shares Outstanding (Millions) 25
 Employees 13,000
 Revenues (TTM) (Millions $) 2,156
 Net Income (TTM) (Millions $) 46
 Cash Flow (TTM) (Millions $) -1
 Capital Exp. (TTM) (Millions $) 93

Business Description


ICU Medical Inc. is a global medical device company that specializes in designing, manufacturing, and selling a broad range of products for critical care and infusion therapy applications. The company was founded in 1984 by Dr. George Lopez and is headquartered in San Clemente, California.

ICU Medical produces a wide range of medical equipment for the healthcare industry, including needle-free systems, closed system transfer devices, catheters, and other accessories that are used in hospitals, clinics, and other healthcare facilities worldwide. The company's product portfolio is focused on intravenous (IV) infusion and critical care therapy, with a particular emphasis on medication delivery systems.

ICU Medical's products are designed to help reduce the risk of infection, contamination, and medication errors, while also improving patient safety, comfort, and convenience. The company's products are used in a variety of medical settings, including operating rooms, intensive care units, emergency departments, and ambulatory care centers.

One of ICU Medical's most innovative products is the "Clave" needle-free injection system, which was first introduced in 2000. The Clave system enables healthcare professionals to safely administer medications, fluids, and blood products to patients without the use of a needle, reducing the risk of needlestick injuries and infection. The Clave system is now used in hospitals and healthcare facilities worldwide and has become a standard of care in many healthcare settings.

Another key product offering from ICU Medical is the ChemoClave system, a closed system transfer device that allows for safe handling of hazardous drugs during chemotherapy infusion. This system helps to protect healthcare workers from exposure to potentially harmful substances, while also reducing the risk of contamination and environmental exposure.

In addition to its core product offerings, ICU Medical also offers a range of complementary services, including clinical education and training, technical support, and consulting services. The company's customer base includes a wide range of healthcare providers, including hospitals, ambulatory care centers, dialysis centers, and infusion therapy providers.

ICU Medical is committed to innovation, quality, and safety, and has received numerous certifications, awards, and recognition for its products and services. The company is focused on continuing to develop and improve its product offerings to help healthcare providers deliver the highest quality care to their patients.


   Company Address: 951 Calle Amanecer San Clemente 92673 CA
   Company Phone Number: 366-2183   Stock Exchange / Ticker: NASDAQ ICUI


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BAX   -1.39%    
BDX   -0.27%    
EW   -0.19%    
MDT        3.48% 
MMM   -5.88%    
RMD   -2.79%    
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 89.40
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 1.94
Price to Sales (Expected) -
Price to Book 1.98
PEG (TTM) -

Financial Strength Current
Quick Ratio -
Working Capital Ratio 2.34
Leverage Ratio (MRQ) 0.85
Total Debt to Equity 0.61
Interest Coverage (TTM) -
Debt Coverage (TTM) 0.1

Per Share Current
Earnings (TTM) 1.86 $
Revenues (TTM) 85.63 $
Cash Flow (TTM) -
Cash -
Book Value 83.87 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 165,875
Net Income per Employee (TTM) 3,565
Receivable Turnover Ratio (TTM) 11.46
Inventory Turnover Ratio (TTM) 2.18
Asset Turnover Ratio (TTM) 0.54

Profitability Ratios Current
Gross Margin (MRQ) 38.97 %
Operating Margin (MRQ) 2.57 %
Net Margin (MRQ) 5.69 %
Net Cash Flow Margin (MRQ) -3.71 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) 1.15 %
Return On Investment (TTM) 1.34 %
Return On Equity (TTM) 2.19 %
Dividend Yield -
Pay out Ratio (TTM) -



Icu Medical Inc's Segments
Infusion Consumables    52.58 % of total Revenue
Infusion Systems    33.94 % of total Revenue
Vital Care    13.67 % of total Revenue
UNITED STATES    59.62 % of total Revenue
EMEA    19.78 % of total Revenue
Asia Pacific    11.02 % of total Revenue
Other foreign countries    9.78 % of total Revenue

  Icu Medical Inc Outlook

On February 27 2024 the Icu Medical Inc provided following guidance

ICU Medical Inc., a prominent company specializing in the creation, production, and distribution of cutting-edge medical devices, has recently disclosed its financial outcomes for the fourth quarter of 2023, which concluded on December 31st. The company, listed on the Nasdaq stock exchange under the ticker symbol ICUI, remains at the forefront of the medical technology industry.

Taking into account the results of the fourth quarter of 2023, ICU Medical Inc. has determined its financial forecast for the fiscal year 2024. The company's estimations for the upcoming year, presented on February 27th, 2024, reflect its commitment to continued growth and success in the medical equipment sector. With a focus ...





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.